Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Zimmer Biomet Holdings

Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.

1 Stock to Buy ASAP to Cash in on the Pickleball Craze

1 Stock to Buy ASAP to Cash in on the Pickleball Craze

As pickleball injuries rise, this medical device stock is perfectly positioned to cash in on the sport’s booming popularity.

3 High-Growth MedTech Stocks to Buy

3 High-Growth MedTech Stocks to Buy

The medtech industry’s long-term growth is fueled by growing demand for medical devices, adoption of cutting-edge technologies, and improved efficiency. Thus, it could be ideal to buy fundamentally solid medtech stocks Baxter International (BAX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC) poised for substantial growth. Keep reading.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

5 Analysts Have This to Say About Zimmer Biomet Holdings

Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings:

SVB Leerink Maintains Outperform Rating for Zimmer Biomet Holdings: Here's What You Need To Know

SVB Leerink has decided to maintain its Outperform rating of Zimmer Biomet Holdings (NYSE:ZBH) and raise its price target from $135.00 to $140.00. Shares of Zimmer Biomet Holdings are trading up 0.82% over the last 24 hours, at $121.67 per share.

Analyst Ratings for Zimmer Biomet Holdings

Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings:

inkl

Read news from The Economist, FT, and more,
with one subscription

Zimmer Biomet: Q1 Earnings Insights

Zimmer Biomet: Q1 Earnings Insights

Zimmer Biomet Holdings (NYSE:ZBH) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Abbott Laboratories vs. Zimmer Biomet Holdings: Which Medical Device Stock is a Better Buy?

Abbott Laboratories vs. Zimmer Biomet Holdings: Which Medical Device Stock is a Better Buy?

The medical devices industry is thriving and the integration of advanced technologies position the industry well for growth. Therefore, prominent players in this space, Abbott Laboratories (ABT) and Zimmer Biomet Holdings (ZBH), should benefit. But which of these stocks is a better buy now? Read more to find out.

Friday Is Your Last Chance To Buy Zimmer Biomet Holdings Before The Dividend Payout

Friday Is Your Last Chance To Buy Zimmer Biomet Holdings Before The Dividend Payout

Friday marks the last chance for investors to receive the next dividend payout from Zimmer Biomet Holdings (NYSE:ZBH).

Analyst Ratings For Zimmer Biomet Holdings

Analyst Ratings For Zimmer Biomet Holdings

Analysts have provided the following ratings for Zimmer Biomet Holdings (NYSE:ZBH) within the last quarter:

Where Zimmer Biomet Holdings Stands With Analysts

Where Zimmer Biomet Holdings Stands With Analysts

Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings within the last quarter:

Should You Scoop Up Shares of Zimmer Biomet Holdings on the Dip?

Should You Scoop Up Shares of Zimmer Biomet Holdings on the Dip?

The shares of healthcare products and solutions provider Zimmer Biomet (ZBH) plunged in price after the company posted a dismal fourth-quarter earnings report. The company cited pandemic-induced challenges as having hampered its performance, while also anticipating these challenges will persist this year. So, will ZBH’s stock be able to gain…

What 16 Analyst Ratings Have To Say About Zimmer Biomet Holdings

What 16 Analyst Ratings Have To Say About Zimmer Biomet Holdings

Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Zimmer Biomet Holdings's Earnings: A Preview

Zimmer Biomet Holdings (NYSE:ZBH) is set to give its latest quarterly earnings report on Monday, 2022-02-07. Here's what investors need to know before the announcement. Analysts estimate that Zimmer Biomet Holdings will likely report an Earnings Per Share (EPS) of $1.98.

Analyst Ratings For Zimmer Biomet Holdings

Over the past 3 months, 10 analysts have published their opinion on Zimmer Biomet Holdings (NYSE:ZBH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

1

Organisations

UnitedHealth Group

Urban Outfitters

Abbott Laboratories

B of A Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

Medical Technology

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

371,113 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play